{"article_title": "Why Celgene Stock Was Down 3% Today -- The Motley Fool", "article_keywords": ["fool", "todayin", "williamson", "takeaways", "motley", "sold", "revenue", "turned", "celgene", "video", "yearoveryear", "quarter", "today", "stock"], "article_url": "http://www.fool.com/investing/general/2014/07/24/why-celgene-stock-was-down-3-today.aspx", "article_text": "Celgene (NASDAQ:CELG) turned in a quarter that beat analyst expectations on the top and bottom lines, with revenue up 17% year-over-year and adjusted EPS up 18% year-over-year, yet the market didn't appear too impressed (the stock sold off about 3% today).\n\nIn the video below, Motley Fool health care analysts Michael Douglass and David Williamson dive into the key takeaways from earnings.", "article_metadata": {"publish_time": "19:05", "description": "What's not to love about Celgene earnings?", "ResponsiveALP": "1Ses_2things-v-single_2-things_50", "author": "Michael Douglass and Dave Williamson", "promo": "What's not to love about Celgene earnings?", "twitter": {"title": "Why Celgene Stock Was Down 3% Today --  The Motley Fool", "description": "What's not to love about Celgene earnings?", "site": "@themotleyfool"}, "msvalidate.01": "8D40D58712924715BAA79D135A6C8DDA", "og": {"site_name": "The Motley Fool", "description": "What's not to love about Celgene earnings?", "title": "Why Celgene Stock Was Down 3% Today --  The Motley Fool", "url": "http://www.fool.com/investing/general/2014/07/24/why-celgene-stock-was-down-3-today.aspx", "image": "https://g.foolcdn.com/image/?url=http%3A%2F%2Fg.foolcdn.com%2Fassets%2Fimages%2Ffool%2Ftmf-logo.png&h=630&w=1200&op=resize", "type": "article"}, "headline": "Why Celgene Stock Was Down 3% Today", "fb": {"admins": 50808187550, "page_id": 7240312795, "app_id": 50808187550}, "bureau": "usmf-health-care", "STORY_UID": "61bbdeb8-136b-11e4-9456-0050569d4be0", "pitch": 823, "date": "2014-07-24T23:05:00Z", "gsa_date": "2014 07 24", "tickers": "CELG", "viewport": "width=device-width, initial-scale=1.0, maximum-scale=1.0"}, "_id": "\"57477af36914bd0286fc9c92\"", "article_summary": "In the video below, Motley Fool health care analysts Michael Douglass and David Williamson dive into the key takeaways from earnings.\nCelgene (NASDAQ:CELG) turned in a quarter that beat analyst expectations on the top and bottom lines, with revenue up 17% year-over-year and adjusted EPS up 18% year-over-year, yet the market didn't appear too impressed (the stock sold off about 3% today)."}